FAQ

183C91

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
012319972017

Related topics

Related topics

1 relation

Broader (1)

Oxazoles

Related mentions per year

Related mentions per year

1945-2018
19401960198020002020
183C91
Oxazoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Bioequivalence and rapid absorption of zolmitriptan nasal spray compared with oral tablets in healthy Japanese subjects.
BACKGROUND AND OBJECTIVE Oral zolmitriptan is highly effective in the acute treatment of migraine. However, nausea and vomiting… (More)
Is this relevant?
2002
2002
Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers.
The objective of this study was to investigate the pharmacokinetics, dose proportionality, and tolerability of a range of single… (More)
Is this relevant?
2002
2002
The pharmacokinetics of the antimigraine compound zolmitriptan in Japanese and Caucasian subjects
Abstract Background. Zolmitriptan is a 5HT1B/1D receptor agonist effective in the acute treatment of migraine. Clinical trials in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2002
2002
Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers.
Two preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray were conducted, each involving 12… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
5-Hydroxytryptamine (5-HT) can produce both vasoconstrictor and vasorelaxant effects in human coronary arteries and the response… (More)
Is this relevant?
1998
1998
The absolute bioavailability and effect of food on the pharmacokinetics of zolmitriptan in healthy volunteers.
AIMS Zolmitriptan (Zomig (formerly 311C90)) is a novel 5-HT1B/1D receptor agonist developed for the acute oral treatment of… (More)
Is this relevant?
1998
1998
The metabolism of zolmitriptan: effects of an inducer and an inhibitor of cytochrome p450 on its pharmacokinetics in healthy volunteers.
Two studies were conducted in healthy volunteers to evaluate the effects of rifampicin and cimetidine on the pharmacokinetics of… (More)
Is this relevant?
1997
1997
No need to adjust the dose of 311C90 (zolmitriptan), a novel anti-migraine treatment, in patients with renal failure not requiring dialysis.
311C90 ("Zomig", zolmitriptan), is a novel and selective, centrally and peripherally acting 5 HT1B/1D receptor agonist in… (More)
Is this relevant?
1997
1997
The novel anti-migraine compound zolmitriptan (Zomig 311C90) has no clinically significant interactions with paracetamol or metoclopramide
Objective: This study investigated potential pharmacokinetic or pharmacodynamic interactions between the novel anti-migraine… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
Review
1997
Review
1997
Potential drug interactions with the novel antimigraine compound zolmitriptan (Zomig, 311C90).
Seven randomized studies in healthy volunteers have investigated interactions between zolmitriptan (Zomig, formerly 311C90), a… (More)
Is this relevant?